BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15109276)

  • 1. Topical methyl aminolevulinate.
    Siddiqui MA; Perry CM; Scott LJ
    Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
    Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
    Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
    Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
    J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
    Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
    Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
    Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
    Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study.
    Freeman M; Vinciullo C; Francis D; Spelman L; Nguyen R; Fergin P; Thai KE; Murrell D; Weightman W; Anderson C; Reid C; Watson A; Foley P
    J Dermatolog Treat; 2003 Jun; 14(2):99-106. PubMed ID: 12775317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.
    Wang BC; Fu C; Qin L; Zeng XY; Liu Q
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101667. PubMed ID: 31978564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy.
    Foley P
    J Dermatolog Treat; 2003; 14 Suppl 3():15-22. PubMed ID: 14522637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
    Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.
    Szeimies RM; Karrer S; Radakovic-Fijan S; Tanew A; Calzavara-Pinton PG; Zane C; Sidoroff A; Hempel M; Ulrich J; Proebstle T; Meffert H; Mulder M; Salomon D; Dittmar HC; Bauer JW; Kernland K; Braathen L
    J Am Acad Dermatol; 2002 Aug; 47(2):258-62. PubMed ID: 12140473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
    Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
    Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
    Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S
    J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.